Recent Updates
Recently added Catalysts
ORIC Positive Sentiment Score: 60/100

ORIC Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference

Monday, November 24, 2025 1 min read
Key Takeaway: ORIC Pharmaceuticals announced its participation in the 8th Annual Evercore Healthcare Conference, scheduled for December 3, 2025. The company will engage in a fireside chat and one-on-one meetings with investors at the event. The discussion will be available for streaming on the company's investor website, with replays accessible for 90 days post-event.

Market Sentiment Analysis

POSITIVE FACTORS

  • ORIC Pharmaceuticals is actively engaging with the investment community.
  • Participation in a prominent healthcare conference reflects the company's visibility.
  • Management's upcoming fireside chat may enhance investor interest.

Full Press Release Details

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will be participating in a fireside chat at the 8th Annual Evercore Healthcare Conference on Wednesday, December 3, 2025, at 11:15 a.m. ET. Management will also be participating in one-on-one meetings.
The webcast of the fireside chat discussion will be available through the investor section of the company’s website at www.oricpharma.com. A replay of the webcast will be available for 90 days following the event.
About ORIC Pharmaceuticals, Inc.
Dominic Piscitelli, Chief Financial Officer
dominic.piscitelli@oricpharma.com

Frequently Asked Questions

When will ORIC Pharmaceuticals participate in the conference?

ORIC Pharmaceuticals will participate on December 3, 2025, at 11:15 a.m. ET.

How can I access the webcast of the fireside chat?

The webcast will be available on ORIC's investor section of their website.

Will there be a replay of the webcast?

Yes, a replay of the webcast will be available for 90 days after the event.

Who is the Chief Financial Officer of ORIC Pharmaceuticals?

Dominic Piscitelli is the Chief Financial Officer of ORIC Pharmaceuticals.

What is the focus of ORIC Pharmaceuticals?

ORIC Pharmaceuticals focuses on developing treatments for therapeutic resistance.

Tags: ORIC Viatris Investor Conferences Healthcare ORIC Pharmaceuticals Evercore Healthcare Conference investor engagement clinical stage oncology therapeutic resistance
Last updated: Nov 24, 2025